12/20/2025
Check out this opportunity for CME credit designed for Physicians offered by the International Antiviral Society-USA in Topics in Medicine (TAM). Learners will be able to describe currently available strategies for the screening, diagnosis, treatment, and prevention of A-E. Learn more: https://iasusa.org/tam/november-december-2025/
The November/December 2025 issue of Topics in Antiviral Medicine™ (TAM) is now available at https://www.iasusa.org/tam/november-december-2025/. This issue offers up to 4.75 CME credits and includes 3 articles showcasing the latest data on currently available strategies for the screening, diagnosis, treatment, and prevention of hepatitis A, B, C, D, and E; important changes in the screening, diagnosis, treatment, and prevention of common sexually transmitted infections; and the 10 questions most commonly received by the National Clinician Consultation Center (NCCC).
Invited Reviews
Prevention and Management of Viral Hepatitis in Primary Care
Emily A. Min, MD, Philip Bolduc, MD
Updates on Testing, Treatment, and Prevention of Sexually Transmitted Infections in the United States, 2025
Caroline Katzman, MD, Natalie Neu, MD, MPH
Top 10 Questions and Answers From the National Clinician Consultation Center: What is Coming Up for Clinicians Across the United States
Parya Saberi, PharmD, MAS, MFA, Carolyn Chu, MD, MSc
Continuing Education
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this issue for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.